XML 58 R38.htm IDEA: XBRL DOCUMENT v3.22.2.2
Stock Incentive Plans (Tables)
9 Months Ended 12 Months Ended
Sep. 30, 2022
Dec. 31, 2021
Stock Incentive Plan Table [Abstract]    
Schedule of stock options outstanding and exercisable

     

Number of
Shares

 

Weighted
Average
Exercise
Price

 

Weighted
Average
Remaining
Contractual
Term
(Years)

 

Average
Intrinsic
Value
(in Thousands)

Outstanding, December 31, 2021

 

30,361,405

 

 

$

3.45

 

6.78

 

$

168,923

Granted

 

391,619

 

 

 

6.17

     

 

 

Exercised

 

(3,139,565

)

 

 

1.16

     

 

21,751

Forfeited or cancelled

 

(663,656

)

 

 

4.51

     

 

 

Outstanding, September 30, 2022

 

26,949,803

 

 

$

3.73

 

6.53

 

 

14,790

Exercisable, September 30, 2022

 

18,698,462

 

 

$

2.83

 

5.66

 

 

14,511

     

Number of
Shares

 

Weighted
Average
Exercise
Price

 

Weighted
Average
Remaining
Contractual
Term
(Years)

 

Average
Intrinsic
Value
(in Thousands)

Outstanding, December 31, 2020

 

28,772,180

 

 

$

2.38

 

6.75

 

$

36,987

Granted

 

5,203,804

 

 

 

6.84

     

 

 

Exercised

 

(2,178,412

)

 

 

0.87

     

 

5,947

Forfeited or cancelled

 

(1,801,023

)

 

 

3.11

     

 

 

Outstanding, September 30, 2021

 

29,996,549

 

 

$

3.22

 

6.85

 

 

172,816

Exercisable, September 30, 2021

 

17,350,839

 

 

$

2.06

 

5.22

 

 

119,390

     

Shares
Available
for Grant

 

Outstanding
Stock
Options

 

Weighted
Average
Exercise
Price Per
Share

 

Weighted
Average
Remaining
Contractual
Term (Years)

 

Average Intrinsic
Value

Outstanding, January 1, 2020

 

378,010

 

 

4,276,480

 

 

$

10.35

 

6.44

 

$

33,785

Authorized

 

650,000

 

 

 

 

 

 

 

 

Options granted

 

(1,446,350

)

 

1,446,350

 

 

 

19.98

 

 

 

Options exercised

 

 

 

(68,679

)

 

 

2.82

 

 

 

1,138

Awards forfeited or cancelled

 

475,875

 

 

(475,875

)

 

 

13.76

 

 

 

Outstanding, December 31, 2020

 

57,535

 

 

5,178,276

 

 

 

13.23

 

6.75

 

 

36,987

Authorized

 

1,200,000

 

 

 

 

 

 

 

 

Options granted

 

(1,134,542

)

 

1,134,542

 

 

 

40.10

 

 

 

Options exercised

 

 

 

(461,290

)

 

 

5.34

 

 

 

9,667

Awards forfeited or cancelled

 

376,245

 

 

(376,245

)

 

 

17.35

 

 

 

Outstanding, December 31, 2021

 

499,238

 

 

5,475,283

 

 

$

19.19

 

6.78

 

$

168,923

Options exercisable as of December 31, 2021

   

 

 

3,322,160

 

 

 

12.23

 

5.32

 

 

125,517

Schedule of stock options outstanding and exercisable  
     

Options Outstanding

 

Options Exercisable

Range of Exercise Prices Per Share

 

Shares
Outstanding

 

Weighted
Average
Remaining
Contractual
Life (Years)

 

Shares
Outstanding

 

Weighted
Average
Remaining
Contractual
Life (Years)

$2.43 – $12.06

 

1,223,100

 

2.63

 

1,223,100

 

2.63

$12.07 – $15.34

 

1,223,673

 

5.91

 

1,154,889

 

5.87

$15.35 – $19.31

 

876,147

 

7.67

 

531,085

 

7.65

$19.32 – $24.17

 

1,156,561

 

8.84

 

404,605

 

8.78

$24.18 – $50.07

 

995,802

 

9.77

 

8,481

 

9.74

   

5,475,283

 

6.78

 

3,322,160

 

5.32

Schedule of weighted average calculated fair value of the options granted to employees

     

September 30,
2022

 

September 30,
2021

Expected dividend yield

 

0

%

 

0

%

Expected volatility

 

51

%

 

42

%

Expected term (years)

 

5.88

 

 

6.01

 

Risk free interest rate

 

2.58

%

 

1.11

%

     

December 31, 2021

 

December 31, 2020

Fair value of common stock

 

$

40.83

 

 

$

20.37

 

Dividend yield

 

 

0

%

 

 

0

%

Expected volatility

 

 

42

%

 

 

44

%

Expected term (years)

 

 

6.01

 

 

 

5.92

 

Risk free interest rate

 

 

1.14

%

 

 

0.64

%

Schedule of operations and comprehensive loss

     

Three Months Ended
September 30,

 

Nine Months Ended
September 30,

   

2022

 

2021

 

2022

 

2021

Cost of revenues

 

$

57

 

$

 

$

68

 

$

Sales and marketing

 

 

1,077

 

 

92

 

 

1,873

 

 

294

Research and development

 

 

4,668

 

 

943

 

 

9,011

 

 

2,939

General and administrative

 

 

3,371

 

 

280

 

 

8,548

 

 

816

Total

 

$

9,173

 

$

1,315

 

$

19,500

 

$

4,049

     

December 31, 2021

 

December 31, 2020

Research and development

 

$

4,434

 

$

3,605

Sales and marketing

 

 

509

 

 

414

General and administrative

 

 

1,379

 

 

1,878

Total

 

$

6,322

 

$

5,897

Schedule of restricted stock unit activity

     

Number of
Shares

 

Weighted
Average
Grant Date
Fair Value

Outstanding, December 31, 2021

 

 

 

$

Granted

 

15,802,990

 

 

 

5.02

Vested

 

(631,925

)

 

 

3.79

Forfeited

 

(68,772

)

 

 

9.77

Outstanding, September 30, 2022

 

15,102,293

 

 

$

5.02

 
Schedule of assumptions under the Monte Carlo simulation model and the calculated fair value of the Market-Based RSUs granted to employees

     

September 30,
2022

Expected volatility

 

52

%

Expected term (years)

 

4

 

Drift rate

 

2.9

%